skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What do you think of averaging down on a small position (less than 1% of our portfolio) of PHO over the next few weeks. Our current Average Cost is $1.61. I'm OK waiting a few years for improvement in their sales volumes. I would think some key question are "Does PHO have an advantage over competitors and can their technology be applied to additional industries beyond semiconductor production?" Their sales are down dramatically, but their margins and cash holdings seem OK.

Thanks.
Read Answer Asked by Robert on August 08, 2019
Q: Can you explain why the price has dropped over the last 3 months, Profit taking after the last quarter? has trading volume increased?
Read Answer Asked by fwb181 on August 08, 2019
Q: Hi 5i
According to the Portfolio Analytics, I should be reducing my exposure to consumer cyclical stocks from 15% down to 10% of my overall portfolio, and I agree I should reduce 3-5%. I currently have MG-3%, CCL.B-4.5%, BYD.UN-4.5%, GIL-2% and the big laggard TSGI-only 1% of my portfolio now.
I'm considering selling TSGI (50% loss) as I'm getting fed up with it, in addition to one of either GIL or MG. What is your opinion on this approach, and would you sell GIL or MG at this time? I'd also like to hear if you would advise a different approach to reducing my exposure. Thanks very much!
Read Answer Asked by Lois on August 07, 2019
Q: This financing news really rubs me the wrong way. The issue price is deeply discounted and the units come with a warrant that is also really cheep assuming the company has any type of decent future. The insiders are participating. This looks like the insiders are taking advantage of the weak current share price to stuff their own pockets and the pockets of their buddies with cheep shares and warrants at the expense of longer term shareholders.
Read Answer Asked by Joel on August 02, 2019
Q: COV has a history of private placements, this includes in 2013, 2017, and now. And insiders can buy provided the Venture exchange provides waivers, including fair value. With 22M common shares outstanding, the just announced offering waters down current shareholders by 10% and if the warrants are exericed, another 10%. WOW, management friendly or what?! Has management stated the use of these funds? And is management attempted to put a floor to the current decline? And as for the warrant exercise price, about 17.5 % higher the offer price, and over 5 years, is management saying the COV price will be range bound for years to come?.......oh, so many un-answered question......wish they would sit down with me for a java talk and provide direct responses!
......bewildering, eh?!.......Tom
Read Answer Asked by Tom on August 02, 2019